World's Best Scientists 2026 revealed!
Award Badge
Medicine
France
2023

D-Index & Metrics

Medicine

D-Index
163
Citations
96788
World Ranking
688
National Ranking
15

Research.com Recognitions

  • 2023 - Research.com Medicine in France Leader Award

Overview

Jean-Yves Blay is affiliated with Claude Bernard University Lyon 1 in France and has a substantial body of research focused on medicine, with a special emphasis on pulmonary and respiratory medicine, oncology, rheumatology, gastroenterology, and molecular biology.

The scientist's work covers several main topics, including:

  • Sarcoma Diagnosis and Treatment
  • Gastrointestinal Tumor Research and Treatment
  • Vascular Tumors and Angiosarcomas
  • Cardiac Tumors and Thrombi
  • Cancer Genomics and Diagnostics
  • Gastric Cancer Management and Outcomes
  • Bone Tumor Diagnosis and Treatments

Jean-Yves Blay has co-authored extensively with several frequent collaborators, including:

  • Antoîne Italiano
  • Nicolas Penel
  • Armelle Dufresne
  • Mehdi Brahmi
  • François Bertucci

The scientist has published numerous papers in prominent journals. Frequent publication venues include:

  • Annals of Oncology
  • Journal of Clinical Oncology
  • ESMO Open
  • European Journal of Cancer
  • Cancers

Among the recent papers authored or co-authored by Jean-Yves Blay are:

  • "Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up" (2021, Annals of Oncology)
  • "Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up" (2021, Annals of Oncology)
  • "The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients" (2020, European Journal of Cancer)
  • "Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial" (2020, The Lancet Oncology)
  • "Gastrointestinal stromal tumours" (2021, Nature Reviews Disease Primers)

Best Publications

  • Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

    Winette T A Van Der Graaf;Jean Yves Blay;Sant P. Chawla;Dong Wan Kim

  • Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial*

    Jaap Verweij;Paolo G. Casali;John Zalcberg;Axel LeCesne

  • Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

    David M. Hyman;Igor Puzanov;Vivek Subbiah;Jason E. Faris

  • Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

    George D Demetri;Peter Reichardt;Yoon-Koo Kang;Jean-Yves Blay

  • Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy

    Carola H. Ries;Michael A. Cannarile;Sabine Hoves;Jörg Benz

  • Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

    P.G. Casali;N. Abecassis;S. Bauer;R. Biagini

  • CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner

    Francois Ghiringhelli;Cédric Ménard;Magali Terme;Caroline Flament

  • NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.

    George D. Demetri;Robert S. Benjamin;Charles D. Blanke;Jean Yves Blay

  • KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

    Maria Debiec-Rychter;Raf Sciot;Axel Le Cesne;Marcus Schlemmer

  • Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

    Ian Judson;Jaap Verweij;Hans Gelderblom;Jörg T Hartmann;Jörg T Hartmann

  • Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO

    Jean Yves Blay;Sylvie Bonvalot;Paolo Casali;Haesun Choi

  • Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience

    Andrés J M Ferreri;Jean Yves Blay;Michele Reni;Felice Pasini

  • Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome

    Michael Gobert;Isabelle Treilleux;Nathalie Bendriss-Vermare;Thomas Bachelot

  • Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer―Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)

    Stefan Sleijfer;Isabelle Ray-Coquard;Zsuzsa Papai;Axel Le Cesne

  • Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

    Patrick Schöffski;Sant Chawla;Robert G. Maki;Antoine Italiano

  • Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas

    Isabelle Ray-Coquard;Claire Cropet;Martine Van Glabbeke;Catherine Sebban

  • Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study

    David Thomas;Robert Henshaw;Keith M Skubitz;Sant Chawla

  • Inhibition of the Differentiation of Dendritic Cells From CD34+ Progenitors by Tumor Cells: Role of Interleukin-6 and Macrophage Colony-Stimulating Factor

    C. Menetrier-Caux;G. Montmain;G. Montmain;M.C. Dieu;M.C. Dieu;C. Bain;C. Bain

  • Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study

    Rolf D Issels;Lars H Lindner;Jaap Verweij;Peter Wust

  • Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO (vol 16, pg 566, 2005)

    JY Blay;S Bonvalot;P Casali;H Choi

Frequent Co-Authors

Axel Le Cesne
Axel Le Cesne Institut Gustave Roussy
Isabelle Ray-Coquard
Isabelle Ray-Coquard Claude Bernard University Lyon 1
Antoine Italiano
Antoine Italiano University of Bordeaux
Christine Chevreau
Christine Chevreau DuPont (United States)
Paolo G. Casali
Paolo G. Casali University of Milan
François Bertucci
François Bertucci Aix-Marseille University
Hans Gelderblom
Hans Gelderblom Leiden University Medical Center
Jean-Michel Coindre
Jean-Michel Coindre University of Bordeaux
Piotr Rutkowski
Piotr Rutkowski Maria Sklodowska-Curie National Research Institute of Oncology
Alessandro Gronchi
Alessandro Gronchi University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The pathway to a medical career in the USA continues to diversify, offering students flexible options online. Those interested in a career shift to nursing, but who do not already hold a nursing license, may consider direct entry msn programs for non-nurses online. These accelerated programs allow students from various backgrounds to earn a master's degree and qualify for nursing practice, often at a faster pace than traditional routes.

Applicants looking for more accessible entry points into nursing may be interested in nursing schools with high acceptance rates. These institutions are ideal for those wanting to overcome common admission barriers. Additionally, prospective nurses who wish to avoid standardized testing can find absn programs that don't require teas, making the path to nursing school even more approachable.

For individuals interested in healthcare but not direct patient care, administrative roles are also in demand. There are reputable medical coding and billing classes online with financial aid, letting students enter this growing field with flexible, affordable study options.

Best Scientists Citing Jean-Yves Blay

Trending Scientists